BCAL Diagnostics is an Australian-owned, ASX listed, biotechnology company. They are pioneering and distributing non-invasive blood tests designed to provide patients with greater confidence in their care. BCAL believes early and accurate detection is key to improving cancer outcomes.
Looking for a particular BCAL Diagnostics employee's phone or email?
BCAL Diagnostics Questions
The BCAL Diagnostics annual revenue was $5.1 million in 2026.
Shane Ryan is the CEO of BCAL Diagnostics.
15 people are employed at BCAL Diagnostics.
BCAL Diagnostics is based in Eveleigh, New South Wales.
The NAICS codes for BCAL Diagnostics are [62151, 621, 6215, 62].
The SIC codes for BCAL Diagnostics are [807, 80].
Top BCAL Diagnostics Employees
-
Shane Ryan
Chief Executive Officer at BCAL Diagnostics
Melbourne, VIC, AU14 -
Mark Faicd
Non Executive Director at BCAL Diagnostics
Canberra, ACT, AU14 -
John Hurrell
Non Executive Director and Advisor at BCAL Diagnostics
Indianapolis, IN, US25+ -
Alexandra Feetham
Head of Product Strategy at BCAL Diagnostics
Randwick, NSW, AU3 -
31
-
Hardik Patel
Quality Coordinator at BCAL Diagnostics
Sydney, NSW, AU1 -
Kalpesh Shah
Medical Laboratory Scientist at BCAL Diagnostics
Sydney, NSW, AU1 -
Sean Barker
Market access and sales at BCAL Diagnostics
Wheeler Heights, NSW, AU2
Related Companies
